Drugs / Ad5.SSTR/TK.RGD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00964756 | Aug 2009 → Dec 2010 | ovarian cancer | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5.SSTR/TK.RGD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00964756 ↗ |
| Route | Other | “Eligible patients were treated intraperitoneally for 3 days with 1 × 10(9) to 1 × 10(12) vp/dose of Ad5.SSTR/TK.RGD” PMID 22510347 ↗ Apr 2012 |